XDPG:LSE:LSE-Xtrackers (IE) Public Limited Company - Xtrackers S&P 500 UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 8778

Change

-6.00 (-0.07)%

Market Cap

USD 0.36B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 592.18B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 331.07B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing XDPG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.37% 82% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.37% 82% B 74% C
Trailing 12 Months  
Capital Gain 28.65% 86% B+ 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.65% 85% B 81% B-
Trailing 5 Years  
Capital Gain 85.92% 89% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 85.92% 88% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 24.48% 90% A- 89% A-
Dividend Return 24.48% 90% A- 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 444.21% 7% C- 6% D-
Risk Adjusted Return 5.51% 34% F 46% F
Market Capitalization 0.36B 65% D 55% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.